Preparation method of health-care composition for tonifying primordial qi, conditioning internal organs, tonifying kidney and strengthening yang

Abstract

The invention relates to the field of preparation of health-care products, in particular to a preparation method of a health-care composition for tonifying primordial qi, conditioning viscera, tonifying kidney and strengthening yang, which comprises the following steps: preparing raw materials into a prepared product with a corresponding target form; periodically detecting the embedding rate of the key prepared product, determining the preparation state of the product according to the embedding rate and the embedding rate change value, and determining a product analysis mode according to the preparation state of the product; if the preparation process is in the first preset preparation state, determining an abnormal continuous state according to the abnormal continuous duration and the embedding rate change value, and determining a processing strategy of the preparation process according to the abnormal continuous state; if the preparation process is in the second preset preparation state, determining an abnormal fluctuation state according to the abnormal fluctuation duration and the abnormal fluctuation trend, and determining an adjustment mode of the preparation process according to the abnormal fluctuation state; and preparing each prepared product into the target health-care composition. According to the invention, the product quality of the key prepared product is improved, and the effectiveness of the health product composition is further improved.

Description

Technical Field

[0001] The present invention relates to the field of health care product preparation, in particular to a method for preparing a health care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang. Background Art

[0002] Microencapsulation of silybum seed oil can effectively isolate the influence of the external environment and prevent oxidation or other reactions of the effective substances in the silybum seed oil from affecting its use effect. However, the current process of microencapsulation of silybum seed oil is often only carried out according to fixed preparation parameters, and the preparation parameters are not adjusted according to the actual preparation effect. Therefore, how to specifically adjust the preparation parameters in the microencapsulation process according to the product status in the actual working scenario is a problem that needs to be solved by those skilled in the art.

[0003] Chinese patent application publication number CN112704126A discloses a method for preparing oil microcapsules, comprising the following steps: adding a wall material, an emulsifier, and an antioxidant to water, mixing uniformly, and shearing and emulsifying to obtain a pre-emulsion, wherein the wall material is a copolymer of sodium starch octenylsuccinate-N,N-dimethylaminoethyl methacrylate-chitosan; adding an oil core material to the pre-emulsion, and sequentially subjecting the mixture to shear emulsification and homogenization to obtain an emulsion; sterilizing the emulsion; spray-drying the sterilized emulsion, and sieving the resulting powder product to obtain the oil microcapsules. This method suffers from the following drawbacks: it fails to determine a targeted analysis method based on changes in product preparation performance during the product preparation process, resulting in a failure to optimize the preparation process based on actual product preparation conditions, and consequently, the quality of the product does not meet actual requirements. Summary of the Invention

[0004] To this end, the present invention provides a health-care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang, and a preparation method thereof, so as to overcome the problem in the prior art that a targeted analysis method is not determined according to changes in the product preparation effect during the product preparation process, and effective adjustments are not made according to the actual preparation process, resulting in the quality of the prepared product not meeting actual needs.

[0005] To achieve the above object, the present invention provides a method for preparing a health-care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang, comprising:

[0006] For preparing the mixed auxiliary preparation product, the auxiliary preparation raw materials are mixed and ground according to the corresponding preset component proportions to obtain the mixed auxiliary preparation product, and the mixed auxiliary preparation product is dried;

[0007] Prepare key products and periodically test the embedding efficiency of the prepared key products;

[0008] The product preparation status is determined according to the embedding rate and the embedding rate change value, and the product analysis method is determined according to the product preparation status, wherein,

[0009] If the preparation process of the key product is in a first preset preparation state, determining the abnormal state according to the duration of the abnormality and the change in the embedding rate, and determining a processing strategy for the preparation process according to the abnormal state, the processing strategy including adjusting a processing parameter ratio or a peristaltic pump speed;

[0010] If the preparation process of the key product is in the second preset preparation state, the abnormal fluctuation state is determined according to the abnormal fluctuation duration and abnormal fluctuation trend, and an adjustment method for the preparation process is determined according to the abnormal fluctuation state, the adjustment method including adjusting the cooling water flow rate or the homogenization pressure;

[0011] Using a mixer to mix the auxiliary preparation product and the key preparation product according to a preset component ratio to obtain a mixed product;

[0012] Conduct humidity and powder particle size testing on mixed products;

[0013] The mixed product that meets the moisture requirements and powder particle size requirements is recorded as the target health care composition.

[0014] Furthermore, during the preparation process of the key preparation product, the embedding rate of the prepared key preparation product is periodically tested, and the preparation status of the product is determined according to the embedding rate and the embedding rate change value, including:

[0015] a first preset preparation state in which the embedding rate is less than or equal to a preset embedding rate;

[0016] a second preset preparation state in which the embedding rate is greater than the preset embedding rate and the embedding rate change value is greater than the preset embedding rate change value.

[0017] Furthermore, for the current detection moment, the product analysis method is determined according to the product preparation status. The product analysis method includes determining the processing strategy of the preparation process according to the abnormal duration and the embedding rate change value, and determining the adjustment method of the preparation process according to the abnormal fluctuation duration and the abnormal fluctuation trend.

[0018] Furthermore, if the preparation process of the key preparation product is in a first preset preparation state, the abnormality persistence state is determined based on the duration of the abnormality and the embedding rate change value, and a processing strategy for the preparation process is determined based on the abnormality persistence state. The processing strategy includes adjusting the processing parameter ratios in the embedding process and determining whether to adjust the peristaltic pump speed based on the yield of the key preparation product at the current detection moment;

[0019] The abnormal continuous state includes a first type of abnormal continuous state in which the abnormal continuous duration is greater than a preset abnormal continuous duration, and a second type of abnormal continuous state in which the abnormal continuous duration is less than or equal to the preset abnormal continuous duration and the embedding rate change value is greater than the preset embedding rate change value;

[0020] Obtain the past interval duration corresponding to each past abnormal moment, and record the maximum value of all past interval durations as the abnormality duration. For a single past abnormal moment, its corresponding past interval duration is the interval duration between the past abnormal moment and the current detection time. The embedding rates measured at all detection moments between the past abnormal moment and the current detection moment are all less than the preset embedding rate.

[0021] Furthermore, if the abnormal state persists, the ratio of the processing parameters in the embedding process is reduced and adjusted according to the embedding rate reference value;

[0022] The decrease in the treatment parameter ratio is negatively correlated with the embedding efficiency reference value;

[0023] The embedding rate reference value is the average embedding rate measured at each detection time within the duration of the abnormality;

[0024] The processing parameter ratio is the ratio of the inlet air temperature to the peristaltic pump speed during the drying process.

[0025] Furthermore, if the second-class abnormality persists, the yield of the key preparation product at the current detection moment is detected. If the yield of the key preparation product is less than the preset yield, the peristaltic pump speed is reduced according to the embedding rate at the current detection moment, and an equipment warning is issued to the user;

[0026] The decrease value of the peristaltic pump rotation speed is negatively correlated with the embedding rate at the current detection moment.

[0027] Furthermore, if the preparation process of the key product is in the second preset preparation state, the abnormal fluctuation state is determined according to the abnormal fluctuation duration and the abnormal fluctuation trend, and an adjustment method for the preparation process is determined according to the abnormal fluctuation state, the adjustment method including adjusting the cooling water flow rate or the homogenization pressure according to the abnormal fluctuation duration;

[0028] The abnormal fluctuation state includes a first type of abnormal fluctuation state in which the abnormal fluctuation duration is greater than a preset abnormal fluctuation duration and the abnormal fluctuation trend is a downward trend, and a second type of abnormal fluctuation state in which the abnormal fluctuation duration is greater than a preset abnormal fluctuation duration and the abnormal fluctuation trend is a stable trend;

[0029] Obtain the stage interval duration corresponding to each abnormal fluctuation stage, and record the minimum value of all stage interval durations as the abnormal fluctuation duration. For a single abnormal fluctuation stage, the corresponding stage interval duration is the interval duration between the starting moment of the abnormal fluctuation stage and the current detection time. The abnormal fluctuation stage is the time period in which the proportion of abnormal change detection moments between the starting moment and the current detection moment is greater than the preset abnormal change moment proportion.

[0030] Furthermore, if the system is in a state of abnormal fluctuation, the cooling water flow rate of the cooling system during the homogenization process is increased and adjusted according to the duration of the abnormal fluctuation.

[0031] The increase in the cooling water flow rate is positively correlated with the duration of the abnormal fluctuation.

[0032] Furthermore, if the pressure is in the second type of abnormal fluctuation state, the homogenization pressure is increased and adjusted according to the duration of the abnormal fluctuation;

[0033] The increase in the homogenization pressure is positively correlated with the duration of the abnormal fluctuation.

[0034] Furthermore, the preset abnormal duration and the preset abnormal fluctuation duration are determined based on reference records;

[0035] The preset abnormal duration is the average duration corresponding to each abnormal duration stage in the reference record, and the embedding rate obtained by each test during the abnormal duration stage is less than the preset embedding rate;

[0036] The preset abnormal fluctuation duration is the average duration corresponding to each abnormal fluctuation stage in the reference record;

[0037] The reference record is a historical record corresponding to a core material whose quality similarity to the core material used in the current preparation process is greater than a preset quality similarity.

[0038] Compared with the prior art, the beneficial effect of the present invention lies in that, in the technical solution of the present invention, the corresponding preparation state is determined according to the embedding rate and its change of the key preparation product during the preparation process, and the analysis method is determined in a targeted manner, and then the optimization method of the preparation process is determined, so that the optimized preparation process is more in line with actual needs. The present invention improves the product quality of the key preparation product obtained, thereby improving the effectiveness of the health care product composition.

[0039] Furthermore, in the present invention, when the preparation process is in the first preset preparation state, the abnormal duration state is determined according to the abnormal duration and the embedding rate change value, and the processing strategy of the preparation process is determined according to the abnormal duration state. The corresponding solution is determined according to whether the low embedding rate is caused by a mutation, so that the selected adjustment parameters are more in line with actual needs, the effectiveness of the preparation process optimization is improved, and the product quality of the key preparation products prepared is thereby improved.

[0040] Furthermore, in the present invention, when the preparation process is in a Class II abnormal continuous state, there is an emergency in the preparation process resulting in poor quality of the key preparation product. If its yield is less than the preset yield, it can be determined that the feed rate is too high and cannot be processed in time, resulting in blockage in the preparation equipment, which in turn leads to a significant decrease in yield and product quality. Reducing the peristaltic pump speed can reduce the feed rate and relieve equipment pressure, thereby improving the product quality of the key preparation product prepared.

[0041] Furthermore, the present invention determines the abnormal fluctuation state according to the abnormal fluctuation duration and the abnormal fluctuation trend, and determines the adjustment method of the preparation process according to the abnormal fluctuation state. By more carefully analyzing the fluctuation state of the product preparation effect to determine the problems existing in the preparation process, and then determining the corresponding adjustment method, the selected adjustment parameters are more in line with actual needs, thereby improving the effectiveness of the preparation process optimization, and thus improving the product quality of the key preparation products prepared. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1 Schematic diagram of the preparation method of the health-care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang of the present invention;

[0043] Figure 2 This is a flow chart of the present invention for determining a product analysis method based on the product preparation status;

[0044] Figure 3 This is a flow chart of the present invention for determining a processing strategy for a preparation process according to an abnormal persistent state;

[0045] Figure 4 The present invention is a flow chart of determining an adjustment method for a preparation process according to an abnormal fluctuation state. DETAILED DESCRIPTION

[0046] In order to make the objects and advantages of the present invention more clearly understood, the present invention is further described below in conjunction with embodiments; it should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0047] The preferred embodiments of the present invention are described below with reference to the accompanying drawings. It should be understood by those skilled in the art that these embodiments are only used to explain the technical principles of the present invention and are not intended to limit the scope of protection of the present invention.

[0048] It should be noted that, in the description of the present invention, terms such as "up", "down", "left", "right", "inside", and "outside" indicating directions or positional relationships are based on the directions or positional relationships shown in the accompanying drawings. This is only for the convenience of description and does not indicate or imply that the device or element must have a specific orientation, be constructed and operated in a specific orientation. Therefore, it cannot be understood as a limitation on the present invention.

[0049] Furthermore, it should be noted that, in the description of the present invention, unless otherwise expressly specified or limited, the terms "mounted," "connected," and "connected" should be understood in a broad sense. For example, they may refer to fixed connections, detachable connections, or integral connections; mechanical connections or electrical connections; direct connections or indirect connections through an intermediate medium; and internal communication between two components. Those skilled in the art will understand the specific meanings of the above terms in the present invention based on specific circumstances.

[0050] See also Figures 1 to 4 As shown, the present invention provides a method for preparing a health-care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang, comprising:

[0051] For preparing the mixed auxiliary preparation product, the auxiliary preparation raw materials are mixed and ground according to the corresponding preset component proportions to obtain the mixed auxiliary preparation product, and the mixed auxiliary preparation product is dried;

[0052] Prepare key products and periodically test the embedding efficiency of the prepared key products;

[0053] The product preparation status is determined according to the embedding rate and the embedding rate change value, and the product analysis method is determined according to the product preparation status, wherein,

[0054] If the preparation process of the key product is in a first preset preparation state, determining the abnormal state according to the duration of the abnormality and the change in the embedding rate, and determining a processing strategy for the preparation process according to the abnormal state, the processing strategy including adjusting a processing parameter ratio or a peristaltic pump speed;

[0055] If the preparation process of the key product is in the second preset preparation state, the abnormal fluctuation state is determined according to the abnormal fluctuation duration and abnormal fluctuation trend, and an adjustment method for the preparation process is determined according to the abnormal fluctuation state, the adjustment method including adjusting the cooling water flow rate or the homogenization pressure;

[0056] Using a mixer to mix the auxiliary preparation product and the key preparation product according to a preset component ratio to obtain a mixed product;

[0057] Conduct humidity and powder particle size testing on mixed products;

[0058] The mixed product that meets the moisture requirements and powder particle size requirements is recorded as the target health care composition.

[0059] The raw materials for preparation in the present invention are determined according to the components of the target health-care composition, wherein the auxiliary raw materials for preparation are raw materials other than the key raw materials for preparation, and the key raw material for preparation is milk thistle seed. The target form of each prepared product in the present invention is a powder form. In the present invention, an infrared drying method is used to detect the humidity of the mixed product, and a laser particle size analysis method is used to detect the powder particle size. How to use the infrared drying method and the laser particle size analysis method to detect the humidity and particle size of the powder is easy to understand for those skilled in the art and will not be described in detail here. The powder particle size requirement is that the powder particle size is greater than 10 microns and less than or equal to 100 microns, and the humidity requirement is that the moisture content of the mixed product is less than 5%. The target health-care composition is the final product obtained by the preparation method according to the present invention. The type and model of the equipment for mixing and grinding and the mixer are not specifically set in the present invention, and the user can select according to the actual preparation process.

[0060] The key prepared product in the present invention is powdered milk thistle seed oil. The process of preparing the key prepared product includes preparing the core material and the wall material into an emulsion to be processed, drying and solidifying the emulsion to be processed by a spray drying method, and screening the powdered microcapsules obtained by drying to remove impurities. The powdered microcapsules after screening are the key prepared product. The core material used in the preparation is milk thistle seed oil. The present invention does not impose specific restrictions on the composition of the wall material and the equipment model used for spray drying. The user can make adaptive settings according to the actual working scenario. In the process of preparing the emulsion, an emulsifier needs to be added and a homogenizer is used. A microjet homogenizer is used in the present invention, which is equipped with a cooling system. The temperature of the emulsion in the homogenizer is regulated by circulating water cooling. How to perform spray drying and how to use the homogenizer are easy to understand for those skilled in the art and will not be elaborated here.

[0061] Specifically, during the preparation process of the key preparation product, the embedding rate of the prepared key preparation product is periodically tested, and the preparation status of the product is determined based on the embedding rate and the embedding rate change value, including:

[0062] a first preset preparation state in which the embedding rate is less than or equal to a preset embedding rate;

[0063] a second preset preparation state in which the embedding rate is greater than the preset embedding rate and the embedding rate change value is greater than the preset embedding rate change value.

[0064] Among them, the present invention applies a cyclic detection cycle, and the duration of the detection cycle can be determined by the user. The higher the user's quality requirements for the key preparation product, the shorter the duration of the detection cycle. A detection cycle duration is provided, and the detection cycle is 10 minutes. At the end of each detection cycle, the embedding rate of the key preparation product prepared within the detection cycle is detected. The present invention uses an ultraviolet spectrophotometer to determine the embedding rate. The measurement process includes dissolving the prepared key preparation product in anhydrous ethanol and performing ultrasonic treatment to ensure its complete dissolution. The absorbance of the prepared solution at a preset wavelength is measured using an ultraviolet spectrophotometer, and the core material concentration is determined based on the absorbance, thereby determining the core material quality of the key preparation product prepared within the detection cycle;

[0065] The embedding rate = (core material mass of the key preparation product prepared within the detection period / core material mass prepared and used within the detection period) × 100%, the embedding rate change value is the absolute value of the difference between the embedding rates detected at the current detection moment and the previous detection moment of the current detection moment, the preset embedding rate and the preset embedding rate change value can be set by the user according to actual needs and historical records. The higher the user's quality requirements for the key preparation product, the smaller the value of the preset embedding rate and the smaller the value of the preset embedding rate change value. A method for determining the preset embedding rate is provided, and the minimum value of the embedding rate in the historical records that meets the user's requirements for the stability and solubility of the key preparation product is recorded as the preset embedding rate. A method for determining the preset embedding rate change value is provided, and 50% of the difference between the minimum and maximum values ​​of the embedding rate in the historical records that meets the user's requirements for the stability and solubility of the key preparation product is recorded as the preset embedding rate change value.

[0066] Specifically, at the current detection moment, the product analysis method is determined according to the product preparation status. The product analysis method includes determining the processing strategy of the preparation process according to the duration of the abnormality and the change value of the embedding rate, and determining the adjustment method of the preparation process according to the duration of the abnormal fluctuation and the abnormal fluctuation trend.

[0067] Specifically, if the preparation process of the key preparation product is in the first preset preparation state, the abnormal persistence state is determined based on the abnormal persistence time and the embedding rate change value, and a processing strategy for the preparation process is determined based on the abnormal persistence state. The processing strategy includes adjusting the processing parameter ratio in the embedding process and determining whether to adjust the peristaltic pump speed based on the yield of the key preparation product at the current detection moment;

[0068] The abnormal continuous state includes a first type of abnormal continuous state in which the abnormal continuous duration is greater than a preset abnormal continuous duration, and a second type of abnormal continuous state in which the abnormal continuous duration is less than or equal to the preset abnormal continuous duration and the embedding rate change value is greater than the preset embedding rate change value;

[0069] Obtain the past interval duration corresponding to each past abnormal moment, and record the maximum value of all past interval durations as the abnormality duration. For a single past abnormal moment, its corresponding past interval duration is the interval duration between the past abnormal moment and the current detection time. The embedding rates measured at all detection moments between the past abnormal moment and the current detection moment are all less than the preset embedding rate.

[0070] Specifically, if the abnormal state persists, the ratio of processing parameters in the embedding process is adjusted downward according to the embedding rate reference value;

[0071] The decrease in the treatment parameter ratio is negatively correlated with the embedding efficiency reference value;

[0072] The embedding rate reference value is the average embedding rate measured at each detection time within the duration of the abnormality;

[0073] The processing parameter ratio is the ratio of the inlet air temperature to the peristaltic pump speed during the drying process.

[0074] Among them, the preparation process is in an abnormal continuous state. The quality of the key preparation product prepared for a long time does not meet the actual requirements. By adjusting the processing parameter ratio, the matching degree between the inlet air temperature and the feed speed is improved to improve the embedding rate of the key preparation product. The processing parameter ratio = inlet air temperature / peristaltic pump speed. It is worth noting that in the process of reducing the processing parameter ratio, it is necessary to ensure that the inlet air temperature and the peristaltic pump speed are both within the preset range. A maximum value and a minimum value of the preset range corresponding to the inlet air temperature are provided. The maximum value of the preset range corresponding to the inlet air temperature is 180°C, and the minimum value of the preset range corresponding to the inlet air temperature is 160°C. A maximum value and a minimum value of the preset range corresponding to the feed speed are provided. The maximum value of the preset range corresponding to the peristaltic pump speed is 17 rpm, and the minimum value of the preset range corresponding to the peristaltic pump speed is 13 rpm. The inlet air temperature is the temperature when the hot air enters the drying chamber during the spray drying process. The peristaltic pump speed is the speed at which its drive motor drives the pump tube to peristaltically deform. The peristaltic pump speed controls the feed speed during the preparation process. The feed speed is the mass of the emulsion entering the drying area per unit time.

[0075] Specifically, if the system is in a Class II abnormal state, the yield of the key preparation product at the current detection moment is detected. If the yield of the key preparation product is less than the preset yield, the peristaltic pump speed is reduced according to the embedding rate at the current detection moment, and an equipment warning is issued to the user.

[0076] The decrease value of the peristaltic pump rotation speed is negatively correlated with the embedding rate at the current detection moment.

[0077] Among them, the yield of the key preparation product = the mass of the key preparation product prepared within the detection period corresponding to the current detection moment / the mass of the emulsion used within the detection period corresponding to the current detection moment. The value of the preset yield can be set by the user according to actual needs and historical records. The higher the user's requirement for the stability of the preparation process, the smaller the value of the preset yield. A method for determining the value of the preset yield is provided, and the average value of the yield of the key preparation product of each preparation process that meets the user's requirement for the stability of the preparation process is recorded as the preset yield. A value of the preset yield is provided, and the value of the preset yield is 50%;

[0078] If the preparation process is in a continuous state of Class II abnormality, it indicates that there is an abnormal quality of the key preparation product caused by an emergency in the preparation process. The problems in the preparation process can be further determined based on the yield of the key preparation product. When the yield of the key preparation product is also abnormal, it can be determined that the preparation equipment is blocked due to excessive feed speed. By adjusting the feed speed in the preparation process, the working pressure of the atomization equipment and the drying equipment can be relieved, and equipment warnings can be issued to users to avoid continued impact of equipment failure on subsequent preparation processes.

[0079] Specifically, if the preparation process of the key preparation product is in the second preset preparation state, the abnormal fluctuation state is determined according to the abnormal fluctuation duration and the abnormal fluctuation trend, and the adjustment method of the preparation process is determined according to the abnormal fluctuation state, and the adjustment method includes adjusting the cooling water flow rate or homogenization pressure according to the abnormal fluctuation duration;

[0080] The abnormal fluctuation state includes a first type of abnormal fluctuation state in which the abnormal fluctuation duration is greater than a preset abnormal fluctuation duration and the abnormal fluctuation trend is a downward trend, and a second type of abnormal fluctuation state in which the abnormal fluctuation duration is greater than a preset abnormal fluctuation duration and the abnormal fluctuation trend is a stable trend;

[0081] Obtain the stage interval duration corresponding to each abnormal fluctuation stage, and record the minimum value of all stage interval durations as the abnormal fluctuation duration. For a single abnormal fluctuation stage, the corresponding stage interval duration is the interval duration between the starting moment of the abnormal fluctuation stage and the current detection time. The abnormal fluctuation stage is the time period in which the proportion of abnormal change detection moments between the starting moment and the current detection moment is greater than the preset abnormal change moment proportion.

[0082] The abnormal change detection ratio = the number of detection moments in the abnormal fluctuation stage where the embedding rate change value is greater than the preset embedding rate change value / the number of detection moments in the abnormal fluctuation stage; the abnormal fluctuation trend is determined based on the embedding rate turning point of the abnormal fluctuation stage to which the current detection moment belongs; the embedding rate turning point includes an increasing turning point and a decreasing turning point; the embedding rate turning point is a detection moment, and the embedding rates before and after the detection moment are both greater than or equal to the embedding rate corresponding to the detection moment, or the embedding rates before and after the detection moment are both less than or equal to the embedding rate at the detection moment; the increasing turning point is when the embedding rates before and after the detection moment are both greater than or equal to the embedding rate corresponding to the detection moment, and the decreasing turning point is when the embedding rates before and after the detection moment are both less than or equal to the embedding rate at the detection moment;

[0083] If the embedding rates corresponding to each growth turning point in the abnormal fluctuation stage to which the current detection moment belongs are all greater than the previous growth turning point, the abnormal fluctuation stage is in an upward trend; if the embedding rates corresponding to each decline turning point in the abnormal fluctuation stage to which the current detection moment belongs are all less than the previous decline turning point, the abnormal fluctuation stage is in a downward trend; if the difference between the maximum and minimum values ​​of the embedding rates corresponding to each turning point in the abnormal fluctuation stage to which the current detection moment belongs is less than or equal to the preset stability amplitude value, the abnormal fluctuation stage is in a stable trend. The preset stability amplitude value can be set by the user according to actual needs and historical records. The higher the user's requirements for the quality stability of key preparation products, the smaller the preset stability amplitude value. A method for determining the preset stability amplitude value is provided, and the historical records that meet the user's requirements for the quality stability of key preparation products are recorded as stable records, and the average value of the change amplitude values ​​in the stability records is recorded as the preset stability amplitude value.

[0084] Specifically, if it is in a state of abnormal fluctuation, the cooling water flow of the cooling system during the homogenization process is increased and adjusted according to the duration of the abnormal fluctuation;

[0085] The increase in the cooling water flow rate is positively correlated with the duration of the abnormal fluctuation.

[0086] Among them, the cooling water flow rate is the volume of cooling water passing through the cooling water inlet of the cooling system of the homogenizer per unit time. If the preparation process is in an abnormal fluctuation state, the embedding rate of the prepared key preparation product is unstable and has a downward trend. This phenomenon is caused by a long period of homogenization treatment, which leads to excessively high temperatures in some areas of the emulsion to be treated, resulting in protein denaturation in the corresponding areas, and then resulting in poor embedding rates of some key preparation products. By adjusting the cooling water flow rate, the existence of areas with excessively high temperatures in the emulsion to be treated can be avoided, and the fluctuation of the embedding rate of the current key preparation product can be improved.

[0087] Specifically, if it is in the second type of abnormal fluctuation state, the homogenization pressure is increased and adjusted according to the duration of the abnormal fluctuation;

[0088] The increase in the homogenization pressure is positively correlated with the duration of the abnormal fluctuation.

[0089] Among them, the homogenization pressure is the microjet pressure in the process of preparing the emulsion to be treated. If the preparation process is in an abnormal fluctuation state, the embedding rate of the key preparation product prepared is unstable, but it always maintains a stable trend. This situation is due to the poor uniformity of the emulsion to be treated, resulting in uneven particle size distribution of the emulsion to be treated, and then causing fluctuations in the embedding rate of the key preparation product prepared. By adjusting the homogenization pressure to improve the particle size uniformity of the emulsion to be treated, the fluctuation of the embedding rate of the current key preparation product is improved.

[0090] Specifically, the preset abnormal duration and the preset abnormal fluctuation duration are determined based on reference records;

[0091] The preset abnormal duration is the average duration corresponding to each abnormal duration stage in the reference record, and the embedding rate obtained by each test during the abnormal duration stage is less than the preset embedding rate;

[0092] The preset abnormal fluctuation duration is the average duration corresponding to each abnormal fluctuation stage in the reference record;

[0093] The reference record is a historical record corresponding to a core material whose mass similarity to a key raw material used in the current preparation process is greater than a preset mass similarity.

[0094] The difference in moisture, impurity mass, peroxide value, and silymarin content between the core material raw materials used in the current preparation process and those used in each historical record are tested. The moisture difference is the absolute value of the difference in moisture content of the core material raw materials used in the two preparations. The impurity mass difference is the absolute value of the difference in mass of insoluble impurities in the core material raw materials used in the two preparations. The peroxide value difference is the absolute value of the difference in peroxide value of the core material raw materials used in the two preparations. The silymarin content difference is the absolute value of the difference in silymarin content of the core material raw materials used in the two preparations.

[0095] The mass similarity is determined based on the moisture difference value, impurity mass difference value, peroxide value difference value and silymarin content difference value of each historical record. A1, A2, A3 and A4 are respectively the moisture difference value, impurity mass difference value, peroxide value difference value and silymarin content difference value, α1, α2, α3 and α4 are respectively the influence coefficients corresponding to the moisture difference value, impurity mass difference value, peroxide value difference value and silymarin content difference value. A value of the influence coefficient of each parameter is provided, and the influence coefficient corresponding to the moisture difference value is 0.4, the influence coefficient corresponding to the impurity mass difference value is 0.1, the influence coefficient corresponding to the peroxide value difference value is 0.25, and the influence coefficient corresponding to the silymarin content difference value is 0.25. Users can select appropriate parameters for determining quality similarity and their corresponding influence coefficients according to actual working conditions.

[0096] The value of the preset quality similarity can be set by the user according to actual needs and historical records. The higher the quality requirement of the user for the key preparation product, the larger the value of the preset quality similarity. A method for setting the value of the preset quality similarity is provided, and the average value of the quality similarity of each reference record of the historical record that meets the user's quality requirement for the key preparation product is recorded as the preset quality similarity.

[0097] The present invention also provides a health-care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang obtained by the preparation method, wherein the composition and the proportion of the preset components are as follows:

[0098] Powdered Milk Thistle Seed Oil: 8.88%, Polydextrose: 7.60%, Lecithin: 7.10%, Cordyceps Militaris Powder: 6.91%, Black Bean Husk Powder: 6.00%, Coconut Milk Powder: 5.98%, Fungus Powder: 5.92%, Skim Milk Powder: 5.40%, Agaricus Blazei Murrill Powder: 3.19%, Fucoidan: 2.97%, Polygonatum Sinensis Powder: 2.97%, Cumin Powder: 2.97%, Soy Protein Isolate: 2.47%, Acerola Fruit Powder: 2.44%, Tremella Fuciformis Powder : 2.00%, Poria powder: 1.98%, citrus fiber: 1.75%, concentrated whey protein powder: 1.48%, virgin coconut oil microcapsule powder: 1.48%, carob extract: 1.48%, lycopene: 1.41%, red bean powder: 1.21%, clove powder: 1.19%, calcium: 1.02%, coix seed powder: 0.99%, noni pulp powder: 0.99%, galactomannan: 0.99%, okra powder: 0.99%, d-nucleic acid Sugar: 0.99%, Mung Bean Powder: 0.99%, Salmon Protein Powder: 0.99%, Sodium Carboxymethyl Cellulose: 0.80%, Yeast Complex: 0.80%, Mulberry Powder: 0.44%, Fish Collagen Peptide Powder: 0.44%, Donkey-hide Gelatin Oligopeptide Powder: 0.44%, Wolfberry Powder: 0.44%, Maca Powder: 0.44%, Xylo-oligosaccharide: 0.36%, Astaxanthin: 0.32%, Citrus Powder: 0.27%, White Kidney Bean Ultrafine Powder: 0.27%, Type II Fish bone collagen: 0.27%, black wolfberry freeze-dried powder: 0.27%, vitamin C: 0.26%, ginseng peptide powder: 0.28%, sea cucumber peptide: 0.25%, lotus seed powder: 0.25%, spinach powder: 0.25%, selenium-enriched yeast powder: 0.1%, theanine: 0.1%, niacin: 0.05%, vitamin B: 0.05%, iron: 0.03%, chromium-enriched yeast powder: 0.03%, zinc: 0.03% and vitamin A: 0.03%.

[0099] Table 1: Different parameters involved in Examples 1 to 16

[0100]

[0101] Table 1: Different parameters involved in Examples 1 to 16

[0102]

[0103] Note: The processing strategy adjustment parameters and adjustment method adjustment parameters in Table 1 are the adjusted parameters.

[0104] Please refer to Table 2, which shows the test results of the product embedding efficiency, target product humidity, and target product particle size in Examples 1 to 16.

[0105] Table 2: Test results of product embedding efficiency, target product humidity and target product particle size in Examples 1 to 16

[0106] Example Product embedding rate / % Target product moisture / % Target product particle size / μm Example 1 73 7 106 Example 2 78 5 102 Example 3 73 5 105 Example 4 79 4 97 Example 5 77 4 101 Example 6 80 4 99 Example 7 83 3 75 Example 8 81 3 80 Example 9 88 3 73 Example 10 87 4 78 Example 11 90 4 72 Example 12 92 3 69 Example 13 93 3 70 Example 14 88 5 73 Example 15 90 3 68 Example 16 93 3 63

[0107] Note: The product embedding rate in Table 2 is the average embedding rate obtained by performing several embedding rate tests on the key products obtained after the preparation is completed. The target product humidity is the humidity of the target health-care composition obtained after the preparation is completed. The target product particle size is the maximum particle size value obtained by performing particle size tests on the target health-care composition obtained after the preparation is completed.

[0108] The above Examples 1 to 5 show that under the first type of abnormal continuous state, by adjusting the processing parameter ratio to improve the matching degree between the inlet air temperature and the feed rate, the encapsulation effect of the key product and the preparation effect of the target health-care composition are improved. The above Examples 6 to 8 show that under the second type of abnormal continuous state, by adjusting the peristaltic pump speed to reduce the feed rate, the working pressure of the atomization equipment and the drying equipment is relieved, thereby avoiding further impact on the preparation process of the subsequent key products, thereby improving the overall preparation effect.

[0109] The above Examples 9 to 13 show that under the first type of abnormal fluctuation state, the cooling water flow rate is adjusted to avoid the presence of an excessively high temperature area in the emulsion to be treated during the homogenizer treatment, which causes protein denaturation in the emulsion to be treated, thereby improving the encapsulation effect of the key product and the preparation effect of the target health-care composition. The above Examples 9, 10 and Examples 14 to 16 show that under the second type of abnormal fluctuation state, the fluctuation of the encapsulation rate can be improved by adjusting the homogenization pressure to further ensure the encapsulation effect of the key product.

[0110] Thus far, the technical solutions of the present invention have been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it will be readily understood by those skilled in the art that the scope of protection of the present invention is obviously not limited to these specific embodiments. Without departing from the principles of the present invention, those skilled in the art may make equivalent changes or substitutions to the relevant technical features, and the technical solutions after such changes or substitutions will fall within the scope of protection of the present invention.

[0111] The foregoing description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Those skilled in the art will readily appreciate that the present invention is susceptible to various modifications and variations. Any modifications, equivalent substitutions, or improvements made within the spirit and principles of the present invention are intended to be within the scope of protection of the present invention.

Claims

1. A method for preparing a health-care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang, characterized in that: include: For preparing the mixed auxiliary preparation product, the auxiliary preparation raw materials are mixed and ground according to the corresponding preset component proportions to obtain the mixed auxiliary preparation product, and the mixed auxiliary preparation product is dried; Prepare key products and periodically test the embedding efficiency of the prepared key products; The product preparation status is determined according to the embedding rate and the embedding rate change value, and the product analysis method is determined according to the product preparation status, wherein, If the preparation process of the key product is in a first preset preparation state, determining the abnormal state according to the duration of the abnormality and the change in the embedding rate, and determining a processing strategy for the preparation process according to the abnormal state, the processing strategy including adjusting a processing parameter ratio or a peristaltic pump speed; If the preparation process of the key product is in the second preset preparation state, the abnormal fluctuation state is determined according to the abnormal fluctuation duration and abnormal fluctuation trend, and an adjustment method for the preparation process is determined according to the abnormal fluctuation state, the adjustment method including adjusting the cooling water flow rate or the homogenization pressure; Using a mixer to mix the auxiliary preparation product and the key preparation product according to a preset component ratio to obtain a mixed product; Conduct humidity and powder particle size testing on mixed products; The mixed product that meets the moisture requirements and powder particle size requirements is recorded as the target health care composition.

2. The preparation method of the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidney and enhancing yang according to claim 1, characterized in that: During the preparation process of key preparation products, the embedding rate of the prepared key preparation products is periodically tested, and the preparation status of the product is determined based on the embedding rate and the embedding rate change value, including: a first preset preparation state in which the embedding rate is less than or equal to a preset embedding rate; a second preset preparation state in which the embedding rate is greater than the preset embedding rate and the embedding rate change value is greater than the preset embedding rate change value.

3. The preparation method of the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidney and enhancing yang according to claim 2, characterized in that: At the current detection moment, the product analysis method is determined according to the product preparation status. The product analysis method includes determining the processing strategy of the preparation process according to the abnormal duration and the embedding rate change value, and determining the adjustment method of the preparation process according to the abnormal fluctuation duration and abnormal fluctuation trend.

4. The method for preparing the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidneys and enhancing yang according to claim 3, characterized in that: If the preparation process of the key preparation product is in the first preset preparation state, the abnormality persistence state is determined based on the abnormality persistence time and the embedding rate change value, and a processing strategy for the preparation process is determined based on the abnormality persistence state. The processing strategy includes adjusting the processing parameter ratios in the embedding process and determining whether to adjust the peristaltic pump speed based on the yield of the key preparation product at the current detection moment; The abnormal continuous state includes a first type of abnormal continuous state in which the abnormal continuous duration is greater than a preset abnormal continuous duration, and a second type of abnormal continuous state in which the abnormal continuous duration is less than or equal to the preset abnormal continuous duration and the embedding rate change value is greater than the preset embedding rate change value; Obtain the past interval duration corresponding to each past abnormal moment, and record the maximum value of all past interval durations as the abnormality duration. For a single past abnormal moment, its corresponding past interval duration is the interval duration between the past abnormal moment and the current detection time. The embedding rates measured at all detection moments between the past abnormal moment and the current detection moment are all less than the preset embedding rate.

5. The method for preparing the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidneys and enhancing yang according to claim 4, characterized in that: If the abnormal state persists, the processing parameter ratio in the embedding process is adjusted downwards according to the embedding rate reference value; The decrease in the treatment parameter ratio is negatively correlated with the embedding efficiency reference value; The embedding rate reference value is the average embedding rate measured at each detection time within the duration of the abnormality; The processing parameter ratio is the ratio of the inlet air temperature to the peristaltic pump speed during the drying process.

6. The method for preparing the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidneys and enhancing yang according to claim 5, characterized in that: If the second-class abnormality persists, the yield of the key preparation product at the current detection moment is detected. If the yield of the key preparation product is less than the preset yield, the peristaltic pump speed is reduced according to the embedding rate at the current detection moment, and an equipment warning is issued to the user; The decrease value of the peristaltic pump rotation speed is negatively correlated with the embedding rate at the current detection moment.

7. The method for preparing the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidneys and enhancing yang according to claim 3, characterized in that: If the preparation process of the key product is in the second preset preparation state, the abnormal fluctuation state is determined according to the abnormal fluctuation duration and the abnormal fluctuation trend, and an adjustment method for the preparation process is determined according to the abnormal fluctuation state, the adjustment method including adjusting the cooling water flow rate or homogenization pressure according to the abnormal fluctuation duration; The abnormal fluctuation state includes a first type of abnormal fluctuation state in which the abnormal fluctuation duration is greater than a preset abnormal fluctuation duration and the abnormal fluctuation trend is a downward trend, and a second type of abnormal fluctuation state in which the abnormal fluctuation duration is greater than a preset abnormal fluctuation duration and the abnormal fluctuation trend is a stable trend; Obtain the stage interval duration corresponding to each abnormal fluctuation stage, and record the minimum value of all stage interval durations as the abnormal fluctuation duration. For a single abnormal fluctuation stage, the corresponding stage interval duration is the interval duration between the starting moment of the abnormal fluctuation stage and the current detection time. The abnormal fluctuation stage is the time period in which the proportion of abnormal change detection moments between the starting moment and the current detection moment is greater than the preset abnormal change moment proportion.

8. The method for preparing the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidneys and enhancing yang according to claim 7, characterized in that: If it is in a state of abnormal fluctuation, the cooling water flow of the cooling system during the homogenization process is increased and adjusted according to the duration of the abnormal fluctuation; The increase in the cooling water flow rate is positively correlated with the duration of the abnormal fluctuation.

9. The method for preparing the health-care composition for replenishing vital energy, regulating internal organs, strengthening the kidneys and enhancing yang according to claim 8, characterized in that: If it is in the second type of abnormal fluctuation state, the homogenization pressure is increased and adjusted according to the duration of the abnormal fluctuation; The increase in the homogenization pressure is positively correlated with the duration of the abnormal fluctuation.

10. The method for preparing the health-care composition for replenishing vital energy, regulating internal organs, strengthening kidneys and enhancing yang according to claim 4 or 7, characterized in that: The preset abnormal duration and the preset abnormal fluctuation duration are determined based on reference records; The preset abnormal duration is the average duration corresponding to each abnormal duration stage in the reference record, and the embedding rate obtained by each test during the abnormal duration stage is less than the preset embedding rate; The preset abnormal fluctuation duration is the average duration corresponding to each abnormal fluctuation stage in the reference record; The reference record is a historical record corresponding to a core material whose quality similarity to the core material used in the current preparation process is greater than a preset quality similarity.

Images